Stay updated on Study Nesvacumab in AMD Clinical Trial
Sign up to get notified when there's something new on the Study Nesvacumab in AMD Clinical Trial page.

Latest updates to the Study Nesvacumab in AMD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record presents details of Regeneron’s completed Phase 1 nesvacumab study, including its participant criteria, treatment cohorts, measured outcomes, and study locations.SummaryDifference40%

- Check15 days agoChange DetectedThe site footer revision identifier was updated from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, with the 403 HTML and message visible on the screen. The previous study details and navigation are replaced by the error view, indicating the content is not accessible on this page.SummaryDifference16%

Stay in the know with updates to Study Nesvacumab in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study Nesvacumab in AMD Clinical Trial page.